Vascular endothelial function in patients with coronary slow flow and the effects of nebivolol

Arquivos Brasileiros de Cardiologia

Volumn 97, Issue 4, 2011, Pages 275-280

  Gunes, Yilmaz ^a   Gumrukcuoglu, Hasan Ali ^b   Akdag, Serkan ^d   Simsek, Hakki ^c   Sahin, Musa ^b   Tuncer, Mustafa ^c  

^a Hisar Intercontinental Hospital   (Turkey)

^b YUZUNCU YIL UNIVERSITY   (Turkey)

^c MEDICAL PARK HOSPITAL   (Turkey)

^d Yuksek Ihtisas Research Hospital   (Turkey)

Author keywords

Calcium channel blockers; Endothelium; Regional blood flow; Vascular physiology

Indexed keywords

ACETYLSALICYLIC ACID; BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; NEBIVOLOL;

ADULT; ANGINA PECTORIS; ARTICLE; BODY MASS; BRACHIAL ARTERY; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; DEVICE; DRUG EFFECT; ECHOGRAPHY; ELECTROCARDIOGRAM; HEART CYCLE; HEART LEFT VENTRICLE EJECTION FRACTION; HEMODYNAMIC PARAMETERS; HUMAN; M MODE ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY; VASCULAR ENDOTHELIUM; VASODILATATION;

ASPIRIN; BENZOPYRANS; BLOOD FLOW VELOCITY; BRACHIAL ARTERY; CASE-CONTROL STUDIES; CORONARY CIRCULATION; DRUG THERAPY, COMBINATION; ENDOTHELIUM, VASCULAR; ETHANOLAMINES; HUMANS; MIDDLE AGED; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 82755172987     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: 10.1590/S0066-782X2011005000105     Document Type: Article

References (36)

1. Tambe AA, Demany MA, Zimmerman HA, Mascarenhas E. Angina pectoris and slow flow velocity of dye in coronary arteries - a new angiographic finding. Am Heart J. 1972;84(1):66-71.
2. Singh S, Kothari SS, Bahl VK. Coronary slow flow phenomenon: an angiographic curiosity. Indian Heart J. 2004;56(6):613-7.
3. Pekdemir H, Cin VG, Cicek D, Camsari A, Akkus N, Döven O, et al. Slow coronary flow may be a sign of diffuse atherosclerosis. Contribution of FFR and IVUS. Acta Cardiol. 2004;59(2):127-33.
4. Mangieri E, Macchiarelli G, Ciavolella M, Barillà F, Avella A, Martinotti A, et al. Slow coronary flow: clinical and histopathological features in patients with otherwise normal epicardial coronary arteries. Cathet Cardiovasc Diagn. 1996;37(4):375-81.
5. Beltrame JF, Limaye SB, Horowitz JD. The coronary slow flow phenomenon - a new coronary microvascular disorder. Cardiology. 2002;97(4):197-202.
6. Agewall S. Is impaired flow-mediated dilatation of the brachial artery a cardiovascular risk factor? Curr Vasc Pharmacol. 2003;1(2):107-9.
7. Teragawa H, Ueda K, Matsuda K, Kimura M, Higashi Y, Oshima T, et al. Relationship between endothelial function in the coronary and brachial arteries. Clin Cardiol. 2005;28(10):460-6.
8. Sezgin AT, Sigirci A, Barutcu I, Topal E, Sezgin N, Ozdemir R, et al. Vascular endothelial function in patients with slow coronary flow. Coron Artery Dis. 2003;14(2):155-61.
9. Ritter JM. Nebivolol: endothelium-mediated vasodilating effect. J Cardiovasc Pharmacol. 2001;38(Suppl. 3):S13-6.
10. Gibson CM, Cannon C P, Delay WL, Dodge JT Jr, Alexander B Jr, Marble SJ, et al. TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation. 1996;93(5):879-83.
11. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al; Chamber Quantification Writing Group; American Society of Echocardiography's Guidelines and Standards Committee; European Association of Echocardiography. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18(12):1440-63.
12. Stroes ESG, Koomans HA, de Bruin TWA, Rabelink TJ. Vascular function in the forearm of hypercholesterolemic patients off and on lipid-lowering medication. Lancet. 1995;346(8973):467-71.
13. Sezgin AT, Barutcu I, Sezgin N, Gullu H, Esen AM, Acikgoz N, et al. Contribution of plasma lipid disturbances to vascular endothelial function in patients with slow coronary flow. Angiology. 2007;57(6):694-701.
14. Heitzer T, Schlinzing T, Krohn K, Meinertz T, Münzel T. Endothelial dysfunction, oxidative stress and risk of cardiovascular events in patients with coronary artery disease. Circulation. 2001;104(22):2638-40.
15. Anderson TJ, Uehata A, Gerhard MD, Meredith I T, Knab S, Delagrange D, et al. Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol. 1995;26(5):1235-41.
16. Sax FL, Cannon RO, Hanson C, Epstein SE. Impaired forearm vasodilator reserve in patients with microvascular angina. Evidence of generalized disorder of vascular function? N Engl J Med. 1987;317(22):1366-70.
17. Sezgin AT, Topal E, Barutcu I, Ozdemir R, Gullu H, Bariskaner E, et al. Impaired left ventricle filling in slow coronary flow phenomenon: an echo-Doppler Study. Angiology. 2005;56(4):397-401.
18. Cannon RO 3rd, Bonow RO, Bacharach SL, Green M V, Rosing DR, Leon MB, et al. Left ventricular dysfunction in patients with angina pectoris, normal epicardial coronary arteries, and abnormal vasodilator reserve. Circulation. 1985;71(2):218-26.
19. Sevimli S, Buyukkaya E, Gundogdu F, Arslan S, Aksakal E, Gürlertop Y, et al. Left ventricular function in patients with coronary slow flow: a tissue Doppler study. Arch Turkh Soc Cardiol. 2007;35:360-5.
20. Gunes Y, Tuncer M, Guntekin U, Ceylan Y, Sahin M, Simsek H. Regional functions of the left ventricle in patients with coronary slow flow and the effects of nebivolol. Ther Adv Cardiovasc Dis. 2009;3(6):441-6.
21. Barutcu I, Sezgin AT, Sezgin N, Gullu H, Esen AM, Topal E, et al. Elevated plasma homocysteine level in slow coronary flow. Int J Cardiol. 2005;101(1):143-5.
22. Labovitz AJ, Lewen MK, Kern M, Vandormael M, Deligonul U, Kennedy H. Evaluation of left ventricular systolic and diastolic dysfunction during transient myocardial ischemia produced by angioplasty. J Am Coll Cardiol. 1987;10(4):748-55.
23. Cesar LA, Ramires JA, Serrano Junior C V, Meneghetti JC, Antonelli RH, da-Luz PL, et al. Slow coronary run-off in patients with angina pectoris: clinical significance and thallium-201 scintigraphic study. Braz J Med Biol Res. 1996;29(5):605-13.
24. Kuhn FE, Mohler ER, Satler L F, Reagan K, Lu DY, Rackley CE. Effects of highdensity lipoprotein on acetylcholine-induced coronary vasoreactivity. Am J Cardiol. 1991;68(15):1425-30.
25. Mosseri M, Yarom R, Gotsman MS, Hasin Y. Histologic evidence for small-vessel coronary artery disease in patients with angina pectoris and patent large coronary arteries. Circulation. 1986;74(5):964-72.
26. Yazici M, Demircan S, Durna K, Sahin M. The role of adrenergic activity in slow flow coronary flow and its relationship to TIMI frame count. Angiology. 2007;58(4):393-400.
27. Beltrame J F, Limaye SB, Wuttke RD, Horowitz JD. Coronary hemodynamic and metabolic studies of the coronary slow flow phenomenon. Am Heart J. 2003;146(1):84-90.
28. Robertson RM, Wood AJ, Vaughn WK, Robertson D. Exacerbation of vasotonic angina pectoris by propranolol. Circulation. 1982;65(2):281-5.
29. Kern MJ, Ganz P, Horowitz JD, Gaspar J, Barry WH, Lorell BH, et al. Potentiation of coronary vasoconstriction by beta-adrenergic blockade in patients with coronary artery disease. Circulation. 1983;67(6):1178-85.
30. Billinger M, Seiler C, Fleisch M, Eberli FR, Meier B, Hess OM. Do beta-adrenergic blocking agents increase coronary flow reserve? J Am Coll Cardiol. 2001;38(7):1866-71.
31. Dessy C, Moniotte S, Ghisdal P, Havaux X, Noirhomme P, Balligand JL. Endothelial beta3-adrenoceptors mediate vasorelaxation of human coronary microarteries through nitric oxide and endothelium-dependent hyperpolarization. Circulation. 2004;110(8):948-54.
32. Dessy C, Saliez J, Ghisdal P, Daneau G, Lobysheva II, Frérart F, et al. Endothelial ß-3-adrenoreceptors mediate nitric oxide-dependent vasorelaxation of coronary microvessels in response to the third-generation ß -blocker nebivolol. Circulation. 2005;112(8):1198-205.
33. Togni M, Vigorito F, Windecker S, Abrecht L, Wenaweser P, Cook S, et al. Does the b-blocker nebivolol increase coronary flow reserve? Cardiovasc Drugs Ther. 2007;21(2):99-108.
34. Gunes Y, Tuncer M, Guntekin U, Ceylan Y The effects of nebivolol on P wave duration and dispersion in patients with coronary slow flow. Anadolu Kardiyol Derg. 2009;9(4):290-5.
35. Albayrak S, Ordu S, Yuksel H, Ozhan H, Yazgan O, Yazici M. Efficacy of nebivolol on flow mediated dilatation in patients with slow coronary flow. Int Heart J. 2009;50(5):545-53.
36. Beltrame JF, Limaye SB, Wuttke RD, Horowitz JD. Coronary hemodynamic and metabolic studies of the coronary slow flow phenomenon. Am Heart J. 2003;146(1):84-90.